Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on October 9, 2013, involving the purchase of Ordinary Shares through the Company's ShareReward Plan at a price of 1560.921 pence per share. The transaction involved:
- Mr P C Thomson: Acquisition of 2 Ordinary Shares under the personal contribution element.
- Mrs K Thomson: Acquisition of 2 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the share price of 1560.921 pence per Ordinary Share on October 9, 2013.
- Confirm the total number of shares acquired by Mr P C Thomson and Mrs K Thomson under the ShareReward Plan.
- Review the company's ShareReward Plan rules regarding personal contributions and company matching elements.